Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06637839 · ClinicalTrials.gov registry record · NA
Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation
A NA study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06637839 is a NA study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 20 participants.
The verdict
NCT06637839, a NA study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a single IR facility. Investigators will randomize patients to receive one of two distinct HIGT interventions or a high step count intervention during standard care.
Interventions
- BEHAVIORAL Moderate-Intensity Locomotor Training Program
- BEHAVIORAL High-Intensity Locomotor Training Program
- BEHAVIORAL High-Step Count Locomotor Training Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2027-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06637839
The ClinicalTrials.gov registry entry for NCT06637839 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Moderate-Intensity Locomotor Training Program is the first listed.
NCT06637839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06637839 about?
NCT06637839 is a clinical study titled "Optimal Dosing of High-Intensity Locomotor Training for Step Attainment and Locomotor Outcomes in Stroke Patients Undergoing Acute Inpatient Rehabilitation". The purpose of this study is to elucidate optimal dosing for High Intensity Gait Training (HIGT) to reduce locomotor disability for those undergoing inpatient rehabilitation (IR) in the subacute phase of stroke recovery. This is a randomized controlled trial conducted at a single IR facility. Inves...
What is the current status of trial NCT06637839?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2027-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT06637839?
The interventions under investigation include: Moderate-Intensity Locomotor Training Program (BEHAVIORAL), High-Intensity Locomotor Training Program (BEHAVIORAL), High-Step Count Locomotor Training Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06637839?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.